Event

Seventh FDA/Alzheimer’s Disease Allies Meeting

November 6, 2017, 9:00 AM-5:00 PM

ACT-AD hosted its Seventh FDA/Alzheimer’s Disease Allies Meeting for patient groups, regulators, researchers and industry. This meeting explored challenges related to clinical meaningfulness in therapeutic development for early Alzheimer’s disease.
View Agenda
See Dr. Kun Jin’s Presentation
See Dr. Richard Keefe’s Presentation
See Dr. Paul Aisen’s Presentation